Table 1 Baseline characteristics of NSCLC patients.
Patient | Histology | Gender | Age at operation (years) | Tumour stage | Previous treatment | Smoking history | Molecular alterations |
|---|---|---|---|---|---|---|---|
1 | Adenocarcinoma | Female | 41 | pT2, pN2 (02/16), G2, R0 pM1 (brain) | None | Yes, 15py | K-ras mutation p. G12C |
EGRF not mutated | |||||||
PDL1 expression negative | |||||||
MET not mutated | |||||||
ROS1 translocation negative | |||||||
3 | Adenocarcinoma | Male | 46 | pT1a, pN0 (0/18), G2, R0 | None | Yes, 30py | Not tested |
7 | Adenocarcinoma | Female | 49 | pT2a, pN0 (0/19), G3, R0 | None | Yes, 35py | Not tested |
6 | Squamous cell carcinoma | Male | 67 | pT4, pN1 (4/38), G2, R1 | None | Yes, 50py | Not tested |
